SIGLEC15 and central nervous system cancer: Our data revealed a significant correlation between the expression levels of immune checkpoint molecules (CD274, CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, TIGIT, and SIGLEC15) and RAB32 in high-grade gliomas (HGG).